The Application of CAR-T Cell Therapy in Relapsed and Refractory Malignant Hematologic Tumors

Clinical trial NCT06911710 · RECRUITING

Trial details

NCT number: NCT06911710
Sponsor: Tianjin Medical University General Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lymphoma, B-cell, Aggressive Non-Hodgkin (B-NHL)AML (Acute Myelogenous Leukemia)Myeloma Multiple B-ALL T-ALL/Lymphoma T-lymphocyte Lymphoma

Start date: 2024-11-09
Primary completion: 2026-02-28
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.